InVitro Capital

How Can You Sell What Doesn’t Exist Yet? If startups should sell first, build best-in-class, then sell like crazy, how do you pitch a product that’s still just a dream in your eye? The trick is finding the fastest, cheapest way to prove two things: 1. The pain you’re solving is real. 2. Your solution actually scratches that itch. You don’t need a polished product. You need a scrappy, low-fidelity idea that validates demand. Here are some real-life proof it works: - Rent the Runway: Before they had an app or a slick platform, the founders ran a barebones test: a call center taking orders for designer dress rentals. Women called, booked, and paid. That was it—no tech, just proof. Only after confirming women craved the service did they build the infrastructure. Today, it’s a $1B+ business.? - Airbnb: The origin story is legendary for a reason. The founders threw up a basic website offering air mattresses in their San Francisco apartment during a sold-out conference. Strangers booked. Cash changed hands. Demand was real. That validation sparked a global marketplace now worth over $100B.? - Dropbox: No product, no problem. They posted a three-minute demo video showing what their file-syncing tool *could* do. Result? 75,000 signups overnight—before a single line of code was written. Validation unlocked $1.7B in funding and a thriving SaaS empire. When I built?Vezeeta, what’s now the Middle East’s biggest consumer health platform—serving 20 million patients across five countries, we started by scheduling doctors’ appointments by hand: calling clinics, slotting patients, texting confirmations. Clunky? Yes. Effective? Absolutely. At InVitro Capital, we call this Hypothesis-Driven Validation: test your hunch against reality before you commit. It starts by a hypothesis that must be validated through real sales. Building without selling first is like pouring concrete without checking the ground—it might hold, but why risk the collapse? Every dollar and hour spent pre-validation is a gamble; post-validation, it’s an investment. We would love to hear from you, if this sounds like an exciting way to build. We are partnering with entrepreneurs, tech leaders and industry experts to be part of this movement. We are now building our second cohort. Exciting news about the first one to come soon. Cofound with us: https://lnkd.in/d5WjMSRn Partner with us: https://lnkd.in/dV5xgFmk

In the world of venture building, efficiency is everything. Unlike traditional VC models that scatter investments across countless startups, venture studios thrive on recyclability—leveraging shared resources, networks, and expertise across a focused portfolio. This creates faster growth, lower costs, and stronger synergies between ventures. What drives the real impact is recyclability: 1) Customer Recyclability Smaller portfolios enable founders to cross-pollinate customers effectively. Think bundled offerings or warm client introductions. In over-diversified portfolios? That synergy disappears. 2) Technology Recyclability A curated portfolio allows ventures to share technology, infrastructure, and dev insights. This speeds up roadmaps and slashes costs. In massive portfolios, this collaboration is rare. 3) Operational Recyclability Fewer startups means you can go deeper: → Offer meaningful mentorship → Provide tailored shared services (HR, legal, finance) → Focus on strategic go-to-market advice When stretched too thin, support becomes generic—and opportunities are missed. The bottom line: Venture studios don’t just launch companies—they build ecosystems with cross-startup synergy. At InVitro Capital, we thrive on recyclability to ensure efficient capital deployment, accelerating growth, and maximizing returns. #venturecapital #investing #startups #venturestudio #technology #privateequity

Ever tried pushing a stalled car uphill? That’s what losing momentum feels like for startups. Here’s the hard truth: Momentum isn’t a luxury – it’s survival fuel. After working with more than a dozen teams, the winners win not because they had the best ideas, but because they mastered the art of never stopping. Here are 3 actionable ways to keep your momentum: 1) The “Restart Price” Will Break You - Slowing down costs 10x more than maintaining speed. I’ve watched brilliant teams collapse because they paused to “perfect” their product while competitors kept iterating. Startups fail due to stalled pivots – not bad ideas. Motion creates market feedback. No Motion = No Data = No Lifeline. 2) Execution Eats Your Strategy (Idea) for Breakfast - Execution drives the vast majority of success.?Your 10th iteration will beat someone’s “perfect” first draft in a blink. 3) Small Wins = Jet Fuel for Teams - It’s about daily proof you’re moving forward. Progress attracts talent, investors, and luck. #startups #entrepreneurship #investing #innovation

OpenAI vs. DeepSeek AI: Competing vs. Catalyzing the AI Revolution The AI race is heating up, and two players—OpenAI and DeepSeek—are taking wildly different approaches: Competing vs. Catalyzing. Let’s dive into how their strategies are shaping the future of AI: - OpenAI’s Revenue Explosion: From $3.7B (2024) to $12.6B (2025)—a jaw-dropping 240% revenue surge, driven almost entirely by its flagship consumer product; ChatGPT - Operator: Disruption or Danger? OpenAI’s launch of its Operator AI agent—a tool that fetches, integrates, and analyzes data across platforms—immediately overshadowed countless startups building similar AI assistants. Many startups were rendered obsolete overnight. ?Why is it dangerous? - Consumer-First Focus: OpenAI’s consumer product; ChatGPT gets priority access to superior models, leaving API-dependent startups with weaker tools. - Resource Shift: As OpenAI builds consumer-facing AI agents, will its core models stagnate, pushing startups to alternatives like DeepSeek? - B2B Expansion? Will OpenAI move beyond APIs into the application layer, directly competing in verticals with its own clients? DeepSeek’s Countermove - Zero-Cost Access: Forget licensing fees. DeepSeek offers free access to its cutting-edge tech, empowering startups to reinvest savings into R&D or proprietary data. - Super Reliable: R3 model produces superior results quantitatively and qualitatively. It’s not anymore the world of the higher the price the better the quality. It is actually the other way around. At InVitro Capital, here’s what we always tell founders: - Abandon Generic Use Cases: Build real-world Vertical fully autonomous AI solutions - Hyper-Specialize: Target specific industries with tailored data (e.g., healthcare or legal -not “one-size-fits-all”) - Diversify LLMs: Leverage multiple foundational models to maximize performance, and reduce risk and dependency The AI revolution isn’t just only about who wins the race at the foundation layer but who and how startups in the application layer will build the future. #AI #OpenAI #DeepSeek #TechStrategy #Startups #Innovation #DataIsGold

The Chasm Between Venture Capital & Private Equity—And Where InVitro Capital Fits Venture Capital (VC) fuels early-stage disruptors, chasing unicorns and massive returns. On the other hand, Private Equity (PE) thrives on mature businesses, leveraging buyouts and optimization to enhance cash flow. Both approaches have their strengths, but there’s a significant gap for companies seeking sustainable, profitable growth without burning through capital or banking on a single moonshot exit. These companies aim to deploy meaningful innovation and truly disrupt industries—but where do they turn? In today’s investment landscape opportunities like foundational LLM models, AI infrastructure, biotech, and diagnostics align well with VC’s risk appetite. The potential rewards are high, though the journey is loaded with high failure rates and the need for extensive capital to back a handful of successful bets. Hence, multiple bets are a must. However, for startups building AI software, AI agentic solutions, and similar technologies, the space can quickly become crowded. In such cases, execution excellence and capital efficiency are fundamental for success. The typical VC model for these startups often leads to excessive dilution, frustrated LPs and investors, and disheartened founders. This is where InVitro Capital steps in. Enter InVitro Capital. We blend the innovation-driven mindset of VC with the operational rigor of PE, delivering value to founders and investors through: - Hands-On Support: Embedded expert teams in product development, marketing, and finance from day one. - Capital Efficiency: Prioritizing viable unit economics early, steering clear of the “grow-at-any-cost” approach. - Flexible, Quicker Exits: Targeting mid-market exits ($50M–$200M) or strategic scaling, offering alternatives to the all-or-nothing success model. - Curated Portfolio: A focused selection of ventures, each with a higher likelihood of sustainable success. Our approach bridges the chasm between VC and PE, offering the best of both worlds: innovation with discipline, and growth with profitability. #venturecapital #privateequity #investment #entrepreneurship #startups #investing #venturestudio #InVitroCapital